Prof Anders Sönnerborg MD, PhD, is professor in infectious diseases and clinical virology at Karolinska Institutet (KI), where he is leading a translational research group at the ANA Futura Lab. The research projects focus on antiviral therapy, HIV cure, and treatment/pathogenesis of COVID-19. He is also senior consultant at the Molecular Virology section of Department of Clinical Microbiology at Karolinska University Hospital. The publication record is 477 peer-reviewed articles with 17,034 citations, H-index 63, and 54 graduated PhD students. He is consultant to the Swedish National Board of Health Welfare, Swedish Medical Product Agency, member of the Scientific advisory group in Antivirals/HIV at the European Medicines Agency (1996-2022), and member of the WHO HIVResNet scientific advisory group. He is a regular grantee from the Swedish Research Council since 1986 and has been involved in numerous EU financed projects as well as NIH project. Prof Sönnerborg is a co-founder of the EuResist and member of its steering committee.
